Table 2 Interventions and treatment in the study group (n=123)
Interventions | All subjects (n=123) | Subjects with CV events (n=30) | Subjects without CV events (n=93) |
|---|---|---|---|
Previous PCI, n (%) | 58 (47) | 13 (43) | 45 (48) |
Previous CABG, n (%) | 20 (16) | 6 (20) | 14 (15) |
Thrombolysis, n (%) | 18 (15) | 3 (10) | 15 (16) |
Drugtreatment | |||
Aspirin, n (%) | 122 (99) | 30 (100) | 92 (99) |
Betablocker, n (%) | 111 (90) | 25 (83) | 86 (92) |
ACE inhibitor, n (%) | 31 (25) | 10 (33) | 21 (23) |
Statin, n (%) | 111 (90) | 28 (93) | 83 (94) |